GTS5:Table of Contents: Difference between revisions
Richard.Glen (talk | contribs) No edit summary |
Richard.Glen (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Growth factor receptors and related signalling pathways ([[:GTS5:Growth factor receptors and related signalling pathways|Overview Page Link]] {{#ifeq: {{#show:GTS5:Growth factor receptors and related signalling pathways|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:# | ==Growth factor receptors and related signalling pathways ([[:GTS5:Growth factor receptors and related signalling pathways|Overview Page Link]] {{#ifeq: {{#show:GTS5:Growth factor receptors and related signalling pathways|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}})== | ||
'''Growth factor receptors''' | '''Growth factor receptors''' | ||
- [[:GTS5:Hereditary papillary renal carcinoma (MET)]] {{#ifeq: {{#show:GTS5:Hereditary papillary renal carcinoma (MET)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Hereditary papillary renal carcinoma (MET)]] {{#ifeq: {{#show:GTS5:Hereditary papillary renal carcinoma (MET)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Multiple endocrine neoplasia type 2 (RET)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 2 (RET)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Multiple endocrine neoplasia type 2 (RET)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 2 (RET)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Juvenile polyposis syndrome (BMPR1A, SMAD4)]] {{#ifeq: {{#show:GTS5:Juvenile polyposis syndrome (BMPR1A, SMAD4)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Juvenile polyposis syndrome (BMPR1A, SMAD4)]] {{#ifeq: {{#show:GTS5:Juvenile polyposis syndrome (BMPR1A, SMAD4)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Hereditary neuroblastoma (ALK, PHOX2B)]] {{#ifeq: {{#show:GTS5:Hereditary neuroblastoma (ALK, PHOX2B)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Hereditary neuroblastoma (ALK, PHOX2B)]] {{#ifeq: {{#show:GTS5:Hereditary neuroblastoma (ALK, PHOX2B)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Encephalocraniocutaneous lipomatosis (FGFR1)]] {{#ifeq: {{#show:GTS5:Encephalocraniocutaneous lipomatosis (FGFR1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Encephalocraniocutaneous lipomatosis (FGFR1)]] {{#ifeq: {{#show:GTS5:Encephalocraniocutaneous lipomatosis (FGFR1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''G-coupled protein receptor pathway''' | '''G-coupled protein receptor pathway''' | ||
- [[:GTS5:Glucagon cell hyperplasia and neoplasia (GCGR)]] {{#ifeq: {{#show:GTS5:Glucagon cell hyperplasia and neoplasia (GCGR)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Glucagon cell hyperplasia and neoplasia (GCGR)]] {{#ifeq: {{#show:GTS5:Glucagon cell hyperplasia and neoplasia (GCGR)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:McCune-Albright syndrome (GNAS)]] {{#ifeq: {{#show:GTS5:McCune-Albright syndrome (GNAS)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:McCune-Albright syndrome (GNAS)]] {{#ifeq: {{#show:GTS5:McCune-Albright syndrome (GNAS)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Sturge-Weber syndrome (GNAQ)]] {{#ifeq: {{#show:GTS5:Sturge-Weber syndrome (GNAQ)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Sturge-Weber syndrome (GNAQ)]] {{#ifeq: {{#show:GTS5:Sturge-Weber syndrome (GNAQ)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''RAS-MAPK pathway''' | '''RAS-MAPK pathway''' | ||
- [[:GTS5:Neurofibromatosis type 1 (NF1)]] {{#ifeq: {{#show:GTS5:Neurofibromatosis type 1 (NF1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Neurofibromatosis type 1 (NF1)]] {{#ifeq: {{#show:GTS5:Neurofibromatosis type 1 (NF1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:NF2-related schwannomatosis (NF2)]] {{#ifeq: {{#show:GTS5:NF2-related schwannomatosis (NF2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:NF2-related schwannomatosis (NF2)]] {{#ifeq: {{#show:GTS5:NF2-related schwannomatosis (NF2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Costello syndrome (HRAS)]] {{#ifeq: {{#show:GTS5:Costello syndrome (HRAS)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Costello syndrome (HRAS)]] {{#ifeq: {{#show:GTS5:Costello syndrome (HRAS)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Noonan syndrome (Various genes)]] {{#ifeq: {{#show:GTS5:Noonan syndrome (Various genes)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Noonan syndrome (Various genes)]] {{#ifeq: {{#show:GTS5:Noonan syndrome (Various genes)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]] {{#ifeq: {{#show:GTS5:Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]] {{#ifeq: {{#show:GTS5:Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''PKA signalling pathway''' | '''PKA signalling pathway''' | ||
- [[:GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)]] {{#ifeq: {{#show:GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)]] {{#ifeq: {{#show:GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:PROS syndrome (PIK3CA)]] {{#ifeq: {{#show:GTS5:PROS syndrome (PIK3CA)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:PROS syndrome (PIK3CA)]] {{#ifeq: {{#show:GTS5:PROS syndrome (PIK3CA)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''WNT/TGFbeta pathway''' | '''WNT/TGFbeta pathway''' | ||
- [[:GTS5:Familial adenomatous polyposis (APC)]] {{#ifeq: {{#show:GTS5:Familial adenomatous polyposis (APC)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Familial adenomatous polyposis (APC)]] {{#ifeq: {{#show:GTS5:Familial adenomatous polyposis (APC)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]] {{#ifeq: {{#show:GTS5:Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]] {{#ifeq: {{#show:GTS5:Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:AXIN2-associated polyposis (AXIN2)]] {{#ifeq: {{#show:GTS5:AXIN2-associated polyposis (AXIN2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:AXIN2-associated polyposis (AXIN2)]] {{#ifeq: {{#show:GTS5:AXIN2-associated polyposis (AXIN2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Serrated polyposis (RNF43)]] {{#ifeq: {{#show:GTS5:Serrated polyposis (RNF43)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Serrated polyposis (RNF43)]] {{#ifeq: {{#show:GTS5:Serrated polyposis (RNF43)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:WT1 related tumour predisposition syndrome (WT1)]] {{#ifeq: {{#show:GTS5:WT1 related tumour predisposition syndrome (WT1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:WT1 related tumour predisposition syndrome (WT1)]] {{#ifeq: {{#show:GTS5:WT1 related tumour predisposition syndrome (WT1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:WAGR syndrome (WT1)]] {{#ifeq: {{#show:GTS5:WAGR syndrome (WT1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:WAGR syndrome (WT1)]] {{#ifeq: {{#show:GTS5:WAGR syndrome (WT1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Multiple endocrine neoplasia type 1 (MEN1)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 1 (MEN1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Multiple endocrine neoplasia type 1 (MEN1)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 1 (MEN1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Peutz-Jeghers syndrome (STK11)]] {{#ifeq: {{#show:GTS5:Peutz-Jeghers syndrome (STK11)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Peutz-Jeghers syndrome (STK11)]] {{#ifeq: {{#show:GTS5:Peutz-Jeghers syndrome (STK11)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] {{#ifeq: {{#show:GTS5:Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] {{#ifeq: {{#show:GTS5:Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Hereditary mixed polyposis syndrome (GREM1)]] {{#ifeq: {{#show:GTS5:Hereditary mixed polyposis syndrome (GREM1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Hereditary mixed polyposis syndrome (GREM1)]] {{#ifeq: {{#show:GTS5:Hereditary mixed polyposis syndrome (GREM1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Hedgehog signalling pathway''' | '''Hedgehog signalling pathway''' | ||
- [[:GTS5:Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]] {{#ifeq: {{#show:GTS5:Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]] {{#ifeq: {{#show:GTS5:Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:SMO-related Curry-Jones syndrome (SMO)]] {{#ifeq: {{#show:GTS5:SMO-related Curry-Jones syndrome (SMO)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:SMO-related Curry-Jones syndrome (SMO)]] {{#ifeq: {{#show:GTS5:SMO-related Curry-Jones syndrome (SMO)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:ELP1-related medulloblastoma predisposition syndrome(ELP1)]] {{#ifeq: {{#show:GTS5:ELP1-related medulloblastoma predisposition syndrome(ELP1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:ELP1-related medulloblastoma predisposition syndrome(ELP1)]] {{#ifeq: {{#show:GTS5:ELP1-related medulloblastoma predisposition syndrome(ELP1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Osteochondromatosis (EXT1, EXT2)]] {{#ifeq: {{#show:GTS5:Osteochondromatosis (EXT1, EXT2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Osteochondromatosis (EXT1, EXT2)]] {{#ifeq: {{#show:GTS5:Osteochondromatosis (EXT1, EXT2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''NF-kB signalling pathway''' | '''NF-kB signalling pathway''' | ||
- [[:GTS5:Brooke-Spiegler syndrome (CYLD)]] {{#ifeq: {{#show:GTS5:Brooke-Spiegler syndrome (CYLD)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Brooke-Spiegler syndrome (CYLD)]] {{#ifeq: {{#show:GTS5:Brooke-Spiegler syndrome (CYLD)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''MTOR and PI3K pathway''' | '''MTOR and PI3K pathway''' | ||
- [[:GTS5:Tuberous sclerosis (TSC1, TSC1)]] {{#ifeq: {{#show:GTS5:Tuberous sclerosis (TSC1, TSC1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Tuberous sclerosis (TSC1, TSC1)]] {{#ifeq: {{#show:GTS5:Tuberous sclerosis (TSC1, TSC1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:PTEN hamartoma tumour syndrome (PTEN)]] {{#ifeq: {{#show:GTS5:PTEN hamartoma tumour syndrome (PTEN)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:PTEN hamartoma tumour syndrome (PTEN)]] {{#ifeq: {{#show:GTS5:PTEN hamartoma tumour syndrome (PTEN)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)]] {{#ifeq: {{#show:GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)]] {{#ifeq: {{#show:GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Transcription factors and regulators''' | '''Transcription factors and regulators''' | ||
- [[:GTS5:Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 5, MAX related tumours (MAX)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 5, MAX related tumours (MAX)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:MAFA-related familial insulinomatosis (MAFA)]] {{#ifeq: {{#show:GTS5:MAFA-related familial insulinomatosis (MAFA)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:MAFA-related familial insulinomatosis (MAFA)]] {{#ifeq: {{#show:GTS5:MAFA-related familial insulinomatosis (MAFA)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Birt-Hogg-Dube syndrome (FLCN)]] {{#ifeq: {{#show:GTS5:Birt-Hogg-Dube syndrome (FLCN)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Birt-Hogg-Dube syndrome (FLCN)]] {{#ifeq: {{#show:GTS5:Birt-Hogg-Dube syndrome (FLCN)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Familial chordoma (TBXT)]] {{#ifeq: {{#show:GTS5:Familial chordoma (TBXT)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Familial chordoma (TBXT)]] {{#ifeq: {{#show:GTS5:Familial chordoma (TBXT)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Hyperparathyroidism jaw tumour syndrome (CDC73)]] {{#ifeq: {{#show:GTS5:Hyperparathyroidism jaw tumour syndrome (CDC73)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Hyperparathyroidism jaw tumour syndrome (CDC73)]] {{#ifeq: {{#show:GTS5:Hyperparathyroidism jaw tumour syndrome (CDC73)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
==Oxidative stress response and metabolism ([[:GTS5:Oxidative stress response and metabolism|Overview Page Link]] {{#ifeq: {{#show:GTS5:Oxidative stress response and metabolism|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:# | ==Oxidative stress response and metabolism ([[:GTS5:Oxidative stress response and metabolism|Overview Page Link]] {{#ifeq: {{#show:GTS5:Oxidative stress response and metabolism|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}})== | ||
'''Angiogenesis''' | '''Angiogenesis''' | ||
- [[:GTS5:Von Hippel-Lindau syndrome (VHL)]] {{#ifeq: {{#show:GTS5:Von Hippel-Lindau syndrome (VHL)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Von Hippel-Lindau syndrome (VHL)]] {{#ifeq: {{#show:GTS5:Von Hippel-Lindau syndrome (VHL)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Krebs cycle''' | '''Krebs cycle''' | ||
- [[:GTS5:SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]] {{#ifeq: {{#show:GTS5:SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]] {{#ifeq: {{#show:GTS5:SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]] {{#ifeq: {{#show:GTS5:Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]] {{#ifeq: {{#show:GTS5:Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Toxic metabolite-mediated disorders''' | '''Toxic metabolite-mediated disorders''' | ||
- [[:GTS5:Hereditary tyrosinaemia type 1 (FAH)]] {{#ifeq: {{#show:GTS5:Hereditary tyrosinaemia type 1 (FAH)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Hereditary tyrosinaemia type 1 (FAH)]] {{#ifeq: {{#show:GTS5:Hereditary tyrosinaemia type 1 (FAH)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
==Cell cycle and apoptosis pathways ([[:GTS5:Cell cycle and apoptosis pathways|Overview Page Link]] {{#ifeq: {{#show:GTS5:Cell cycle and apoptosis pathways|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:# | ==Cell cycle and apoptosis pathways ([[:GTS5:Cell cycle and apoptosis pathways|Overview Page Link]] {{#ifeq: {{#show:GTS5:Cell cycle and apoptosis pathways|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}})== | ||
'''P53 pathway''' | '''P53 pathway''' | ||
- [[:GTS5:Li-Fraumeni syndrome (TP53)]] {{#ifeq: {{#show:GTS5:Li-Fraumeni syndrome (TP53)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Li-Fraumeni syndrome (TP53)]] {{#ifeq: {{#show:GTS5:Li-Fraumeni syndrome (TP53)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''RB pathway''' | '''RB pathway''' | ||
- [[:GTS5:Retinoblastoma syndrome (RB1)]] {{#ifeq: {{#show:GTS5:Retinoblastoma syndrome (RB1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Retinoblastoma syndrome (RB1)]] {{#ifeq: {{#show:GTS5:Retinoblastoma syndrome (RB1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Multiple endocrine neoplasia type 4 (CDKN1B)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 4 (CDKN1B)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Multiple endocrine neoplasia type 4 (CDKN1B)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 4 (CDKN1B)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)]] {{#ifeq: {{#show:GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)]] {{#ifeq: {{#show:GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:CDK4-related melanoma predisposition syndrome (CDK4)]] {{#ifeq: {{#show:GTS5:CDK4-related melanoma predisposition syndrome (CDK4)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:CDK4-related melanoma predisposition syndrome (CDK4)]] {{#ifeq: {{#show:GTS5:CDK4-related melanoma predisposition syndrome (CDK4)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''FAS pathway''' | '''FAS pathway''' | ||
- [[:GTS5:Autoimmune lymphoproliferative syndrome (FAS)]] {{#ifeq: {{#show:GTS5:Autoimmune lymphoproliferative syndrome (FAS)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Autoimmune lymphoproliferative syndrome (FAS)]] {{#ifeq: {{#show:GTS5:Autoimmune lymphoproliferative syndrome (FAS)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
==DNA repair and genomic stability ([[:GTS5:DNA repair and genomic stability|Overview Page Link]] {{#ifeq: {{#show:GTS5:DNA repair and genomic stability|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:# | ==DNA repair and genomic stability ([[:GTS5:DNA repair and genomic stability|Overview Page Link]] {{#ifeq: {{#show:GTS5:DNA repair and genomic stability|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}})== | ||
'''Mismatch repair''' | '''Mismatch repair''' | ||
- [[:GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]] {{#ifeq: {{#show:GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]] {{#ifeq: {{#show:GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]] {{#ifeq: {{#show:GTS5:Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]] {{#ifeq: {{#show:GTS5:Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]] {{#ifeq: {{#show:GTS5:Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]] {{#ifeq: {{#show:GTS5:Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Homologous recombination''' | '''Homologous recombination''' | ||
- [[:GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] {{#ifeq: {{#show:GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] {{#ifeq: {{#show:GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:PALB2-related cancer predisposition syndrome (PALB2)]] {{#ifeq: {{#show:GTS5:PALB2-related cancer predisposition syndrome (PALB2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:PALB2-related cancer predisposition syndrome (PALB2)]] {{#ifeq: {{#show:GTS5:PALB2-related cancer predisposition syndrome (PALB2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] {{#ifeq: {{#show:GTS5:RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] {{#ifeq: {{#show:GTS5:RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Fanconi anaemia (FANC genes)]] {{#ifeq: {{#show:GTS5:Fanconi anaemia (FANC genes)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Fanconi anaemia (FANC genes)]] {{#ifeq: {{#show:GTS5:Fanconi anaemia (FANC genes)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Base excision repair genes''' | '''Base excision repair genes''' | ||
- [[:GTS5:MUTYH-associated polyposis (MUTYH)]] {{#ifeq: {{#show:GTS5:MUTYH-associated polyposis (MUTYH)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:MUTYH-associated polyposis (MUTYH)]] {{#ifeq: {{#show:GTS5:MUTYH-associated polyposis (MUTYH)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:NTHL1-related tumour syndrome (NTHL1)]] {{#ifeq: {{#show:GTS5:NTHL1-related tumour syndrome (NTHL1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:NTHL1-related tumour syndrome (NTHL1)]] {{#ifeq: {{#show:GTS5:NTHL1-related tumour syndrome (NTHL1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:MBD4-associated neoplasia syndrome (MBD4)]] {{#ifeq: {{#show:GTS5:MBD4-associated neoplasia syndrome (MBD4)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:MBD4-associated neoplasia syndrome (MBD4)]] {{#ifeq: {{#show:GTS5:MBD4-associated neoplasia syndrome (MBD4)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Deficient nucleotide excision repair (NER) of DNA damage''' | '''Deficient nucleotide excision repair (NER) of DNA damage''' | ||
- [[:GTS5:Xeroderma Pigmentosum]] {{#ifeq: {{#show:GTS5:Xeroderma Pigmentosum|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Xeroderma Pigmentosum]] {{#ifeq: {{#show:GTS5:Xeroderma Pigmentosum|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Non-homologous end joining (NHEJ)''' | '''Non-homologous end joining (NHEJ)''' | ||
- [[:GTS5:Ataxia-telangiectasia syndrome (ATM)]] {{#ifeq: {{#show:GTS5:Ataxia-telangiectasia syndrome (ATM)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Ataxia-telangiectasia syndrome (ATM)]] {{#ifeq: {{#show:GTS5:Ataxia-telangiectasia syndrome (ATM)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]] {{#ifeq: {{#show:GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]] {{#ifeq: {{#show:GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Nijmegen breakage syndrome (NBN)]] {{#ifeq: {{#show:GTS5:Nijmegen breakage syndrome (NBN)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Nijmegen breakage syndrome (NBN)]] {{#ifeq: {{#show:GTS5:Nijmegen breakage syndrome (NBN)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''DNA Polymerization''' | '''DNA Polymerization''' | ||
- [[:GTS5:Polymerase proofreading-associated polyposis (POLD1, POLE)]] {{#ifeq: {{#show:GTS5:Polymerase proofreading-associated polyposis (POLD1, POLE)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Polymerase proofreading-associated polyposis (POLD1, POLE)]] {{#ifeq: {{#show:GTS5:Polymerase proofreading-associated polyposis (POLD1, POLE)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Helicases''' | '''Helicases''' | ||
- [[:GTS5:Bloom syndrome (BLM)]] {{#ifeq: {{#show:GTS5:Bloom syndrome (BLM)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Bloom syndrome (BLM)]] {{#ifeq: {{#show:GTS5:Bloom syndrome (BLM)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Werner syndrome (WRN)]] {{#ifeq: {{#show:GTS5:Werner syndrome (WRN)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Werner syndrome (WRN)]] {{#ifeq: {{#show:GTS5:Werner syndrome (WRN)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Rothmund-Thomson syndrome (ANAPC1, RECQL4)]] {{#ifeq: {{#show:GTS5:Rothmund-Thomson syndrome (ANAPC1, RECQL4)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Rothmund-Thomson syndrome (ANAPC1, RECQL4)]] {{#ifeq: {{#show:GTS5:Rothmund-Thomson syndrome (ANAPC1, RECQL4)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:DDX41-related haematologic tumour predisposition syndrome (DDX41)]] {{#ifeq: {{#show:GTS5:DDX41-related haematologic tumour predisposition syndrome (DDX41)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:DDX41-related haematologic tumour predisposition syndrome (DDX41)]] {{#ifeq: {{#show:GTS5:DDX41-related haematologic tumour predisposition syndrome (DDX41)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Chromosomal non-dysjunction (aneuploidy) syndromes''' | '''Chromosomal non-dysjunction (aneuploidy) syndromes''' | ||
- [[:GTS5:Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]] {{#ifeq: {{#show:GTS5:Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]] {{#ifeq: {{#show:GTS5:Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Klinefelter syndrome]] {{#ifeq: {{#show:GTS5:Klinefelter syndrome|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Klinefelter syndrome]] {{#ifeq: {{#show:GTS5:Klinefelter syndrome|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Turner syndrome]] {{#ifeq: {{#show:GTS5:Turner syndrome|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Turner syndrome]] {{#ifeq: {{#show:GTS5:Turner syndrome|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Down syndrome]] {{#ifeq: {{#show:GTS5:Down syndrome|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Down syndrome]] {{#ifeq: {{#show:GTS5:Down syndrome|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
==Telomere maintenance ([[:GTS5:Telomere maintenance|Overview Page Link]] {{#ifeq: {{#show:GTS5:Telomere maintenance|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:# | ==Telomere maintenance ([[:GTS5:Telomere maintenance|Overview Page Link]] {{#ifeq: {{#show:GTS5:Telomere maintenance|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}})== | ||
'''Telomere biology disorders''' | '''Telomere biology disorders''' | ||
- [[:GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] {{#ifeq: {{#show:GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] {{#ifeq: {{#show:GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]] {{#ifeq: {{#show:GTS5:POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]] {{#ifeq: {{#show:GTS5:POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
==Epigenetic drivers and chromatin remodelling ([[:GTS5:pigenetic drivers and chromatin remodelling|Overview Page Link]] {{#ifeq: {{#show:GTS5:pigenetic drivers and chromatin remodelling|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:# | ==Epigenetic drivers and chromatin remodelling ([[:GTS5:pigenetic drivers and chromatin remodelling|Overview Page Link]] {{#ifeq: {{#show:GTS5:pigenetic drivers and chromatin remodelling|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}})== | ||
'''Imprinting disorders''' | '''Imprinting disorders''' | ||
- [[:GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]] {{#ifeq: {{#show:GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]] {{#ifeq: {{#show:GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Histone and DNA methylation''' | '''Histone and DNA methylation''' | ||
- [[:GTS5:Enchondromatosis (IDH1, IDH2)]] {{#ifeq: {{#show:GTS5:Enchondromatosis (IDH1, IDH2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Enchondromatosis (IDH1, IDH2)]] {{#ifeq: {{#show:GTS5:Enchondromatosis (IDH1, IDH2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''Chromatin remodelling pathway''' | '''Chromatin remodelling pathway''' | ||
- [[:GTS5:Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]] {{#ifeq: {{#show:GTS5:Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]] {{#ifeq: {{#show:GTS5:Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Schwannomatosis (SMARCB1, LZTR1)]] {{#ifeq: {{#show:GTS5:Schwannomatosis (SMARCB1, LZTR1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Schwannomatosis (SMARCB1, LZTR1)]] {{#ifeq: {{#show:GTS5:Schwannomatosis (SMARCB1, LZTR1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)]] {{#ifeq: {{#show:GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)]] {{#ifeq: {{#show:GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:Weaver syndrome (EZH2)]] {{#ifeq: {{#show:GTS5:Weaver syndrome (EZH2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Weaver syndrome (EZH2)]] {{#ifeq: {{#show:GTS5:Weaver syndrome (EZH2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
==RNA regulation ([[:GTS5:RNA regulation|Overview Page Link]] {{#ifeq: {{#show:GTS5:RNA regulation|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:# | ==RNA regulation ([[:GTS5:RNA regulation|Overview Page Link]] {{#ifeq: {{#show:GTS5:RNA regulation|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}})== | ||
'''MicroRNA''' | '''MicroRNA''' | ||
- [[:GTS5:DICER1-related tumour predisposition syndrome (DICER1)]] {{#ifeq: {{#show:GTS5:DICER1-related tumour predisposition syndrome (DICER1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:DICER1-related tumour predisposition syndrome (DICER1)]] {{#ifeq: {{#show:GTS5:DICER1-related tumour predisposition syndrome (DICER1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
- [[:GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] {{#ifeq: {{#show:GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] {{#ifeq: {{#show:GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
'''RNA splicing''' | '''RNA splicing''' | ||
- [[:GTS5:Goldenhar syndrome (MYT1, SF3B2)]] {{#ifeq: {{#show:GTS5:Goldenhar syndrome (MYT1, SF3B2)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:Goldenhar syndrome (MYT1, SF3B2)]] {{#ifeq: {{#show:GTS5:Goldenhar syndrome (MYT1, SF3B2)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||
==Protein regulation ([[:GTS5:Protein regulation|Overview Page Link]] {{#ifeq: {{#show:GTS5:Protein regulation|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:# | ==Protein regulation ([[:GTS5:Protein regulation|Overview Page Link]] {{#ifeq: {{#show:GTS5:Protein regulation|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}})== | ||
'''Ubiquitin pathway''' | '''Ubiquitin pathway''' | ||
- [[:GTS5:BAP1-related tumour predisposition syndrome (BAP1)]] {{#ifeq: {{#show:GTS5:BAP1-related tumour predisposition syndrome (BAP1)|?Page Status|default=Complete}} | Complete | <span style="color:# | - [[:GTS5:BAP1-related tumour predisposition syndrome (BAP1)]] {{#ifeq: {{#show:GTS5:BAP1-related tumour predisposition syndrome (BAP1)|?Page Status|default=Complete}} | Complete | <span style="color:#1e9092"> Complete </span>}} | ||